Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.

Shiraishi Y, Kishimoto J, Sugawara S, Mizutani H, Daga H, Azuma K, Matsumoto H, Hataji O, Nishino K, Mori M, Shukuya T, Saito H, Tachihara M, Hayashi H, Tsuya A, Wakuda K, Yanagitani N, Sakamoto T, Miura S, Hata A, Okada M, Kozuki T, Sato Y, Harada T, Takayama K, Yamamoto N, Nakagawa K, Okamoto I

Open source

DOI: 10.1001/jamaoncol.2023.5258
Published: 2024 Mar 1
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2023.5258,
  title = {Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.},
  author = {Shiraishi Y and Kishimoto J and Sugawara S and Mizutani H and Daga H and Azuma K and Matsumoto H and Hataji O and Nishino K and Mori M and Shukuya T and Saito H and Tachihara M and Hayashi H and Tsuya A and Wakuda K and Yanagitani N and Sakamoto T and Miura S and Hata A and Okada M and Kozuki T and Sato Y and Harada T and Takayama K and Yamamoto N and Nakagawa K and Okamoto I},
  year = {2024},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2023.5258},
  url = {https://doi.org/10.1001/jamaoncol.2023.5258}
}

RIS

TY  - JOUR
TI  - Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
AU  - Shiraishi Y
AU  - Kishimoto J
AU  - Sugawara S
AU  - Mizutani H
AU  - Daga H
AU  - Azuma K
AU  - Matsumoto H
AU  - Hataji O
AU  - Nishino K
AU  - Mori M
AU  - Shukuya T
AU  - Saito H
AU  - Tachihara M
AU  - Hayashi H
AU  - Tsuya A
AU  - Wakuda K
AU  - Yanagitani N
AU  - Sakamoto T
AU  - Miura S
AU  - Hata A
AU  - Okada M
AU  - Kozuki T
AU  - Sato Y
AU  - Harada T
AU  - Takayama K
AU  - Yamamoto N
AU  - Nakagawa K
AU  - Okamoto I
PY  - 2024
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2023.5258
UR  - https://doi.org/10.1001/jamaoncol.2023.5258
ER  -

APA

Y, S., J, K., S, S., H, M., H, D., K, A., H, M., O, H., K, N., M, M., T, S., H, S., M, T., H, H., A, T., K, W., N, Y., T, S., S, M., A, H., M, O., T, K., Y, S., T, H., K, T., N, Y., K, N., & I, O. (2024). Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2023.5258

Source records

pubmed · retrieved 2026-09-25T17:24:17.179Z